EUVIMEDEUVIMED entdecken
Crossref

Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility

Reem Darwesh,, Balsam Fahad Sofi, Nihal S. Elbialy, Jaber Hussain Alsalah

Engineered Science · 2026

DOI: 10.30919/es2173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Engineered Science, 2026. Verfasst von Reem Darwesh, und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Darwesh,, R., Sofi, B. F., Elbialy, N. S., & Alsalah, J. H. (2026). Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. https://doi.org/10.30919/es2173

Vancouver

Darwesh, R, Sofi BF, Elbialy NS, Alsalah JH. Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility. Engineered Science. 2026. doi:10.30919/es2173

BibTeX
@article{Darwesh2026,
  author = {Darwesh,, Reem and Sofi, Balsam Fahad and Elbialy, Nihal S. and Alsalah, Jaber Hussain},
  title = {Intranasal Delivery of PEGylated Mesoporous Silica Nanoparticles for Enhanced Brain Targeting: In Vivo Evaluation of Pharmacokinetics, Biodistribution and Biocompatibility},
  journal = {Engineered Science},
  year = {2026},
  doi = {10.30919/es2173}
}
Kostenlos starten →